COVID-19:カナダ、アビガン(ファビピラビル)の第2相治験:先住民保健局(FNIHB)(動画):  Indigenous Services eyeing Canadian trial of antiviral drug that could prevent COVID-19:  土著服务局在加拿大进行抗病毒药物试验,该药物可预防COVID-19

flu, Drugs, Pharmaceutical

COVID-19:小野薬品の「フオイパン」登場:新型コロナ第Ⅰ相臨床試験へ:  COVID-19: Ono Pharmaceutical’s “Foipan” Appears: New Corona Phase I Clinical Trial :  COVID-19:出现Ono Pharmaceutical的“ Foipan”:新的电晕I期临床试验

flu, Drugs, Pharmaceutical

COVID-19:アビファビル60,000人分6月病院に配布:露RDIFのアビガン後発薬(動画):  RDIF to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia:  RDIF将提供60,000道在俄罗斯注册的首批COVID-19药物课程,

flu, Drugs, Pharmaceutical

COVID-19:インド、アビガン(Favipiravir)治験良好:Raghava Life Sciences(動画):  (RLS)Favipiravir drug working better on Covid:  (RLS)法维拉韦药物在Covid上效果更好

flu, Drugs, Pharmaceutical

COVID-19:露保健省、アビガン後発薬を暫定承認:RDIFのアビファビル(Avifavir)(動画):  Russian Ministry approves the first COVID-19 drug Avifavir by JV of RDIF/ChemRar Moscow:  俄罗斯卫生部批准了RDIF的合资企业和ChemRar Moscow共同生产的首批COVID-19药物阿维法韦,

flu, Drugs, Pharmaceutical

Posts navigation